![](https://investorshub.advfn.com/uicon/358623.png?cb=1554503635)
Friday, November 03, 2017 9:36:53 PM
Dear XXX,
With the recent announcement by the Trump administration to declare the opioid crisis a Public Health Emergency, one thing became inevitably clear last week - The time is now to take every measure available to combat this epidemic. This includes leveraging the use of medications for opioid addiction to confront America's drug overdose crisis.
On the heels of this monumental announcement, there has never been a more opportune time for leaders in Regulatory Affairs, Clinical Operations, Medical Affairs, Government Relations/Policy, Pharmacovigilance, Generic and Specialty Products to convene at the Abuse-Deterrent Formulations Critical Update Forum, taking place December 7th in Philadelphia, PA. Key stakeholders are set to unite to assess the lay of the land and the pending implications for bio/pharma manufacturers. Join expert faculty to discuss data that supports the efficacy of ADFs and their role in controlling the opioid epidemic.
A vast array of leading organizations will drive the timely dialogue, including Center for Lawful Access & Abuse Deterrence, Depomed, Inc., Collegium Pharmaceutical, Egalet, Tufts University, Journal of Pain Research, INC Research/inVentiv Health and many others. Download the brochure and register today!
Kind Regards,
Vivian Juter Frankel
Conference Producer, ADF Critical Update Forum 2017
CBI, a division of UBM Americas
You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM